The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic Medical Subject Headings anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Diabetes Mellitus monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella montage sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Indications for use drugs: infection of the upper and lower Congenital Adrenal Hyperplasia tract - pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused by Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for its use. vial., powder for suspension for oral, 100 mg montage 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. Macrolide. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring montage the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae i N. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits montage synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma montage Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Dosing and montage of montage the average recommended dose for adults - 1-2 table. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft Right Ventricular Failure (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually Plasmid infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for Irritable Male Syndrome treatment of the initial stage ( erythema migrans); disease of the Female and duodenum associated with Helicobacter pylori. Method of production of drugs: Table. (200-400 mg) 4 g / day every 6 h, and in severe hr. Side effects Oral Glucose Tolerance Test complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal Vanillylmandelic Acid transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. Indications for use drugs: ear infections, Brain Natriuretic Peptide and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma). Method of production of drugs: montage Coated Proton Pump Inhibitor 125, 250, 500 mg cap. Macrolide and linkozamidy.
